Lonza | LONN - Net Income

Stock Price
508.60
Daily Change
5.60 1.11%
Monthly
1.99%
Yearly
0.71%
Q2 Forecast
499.29

Lonza reported CHF426M in Net Income for its fiscal semester ending in June of 2025.





Net Income Change Date
Akzo Nobel EUR 598M 792M Dec/2025
Alcon AG USD 217M 20M Dec/2025
Almirall EUR 19.58M 7M Dec/2025
AstraZeneca USD 2.33B 207M Dec/2025
BASF EUR 560M 388M Dec/2025
Bayer EUR -3.76B 2.79B Dec/2025
Beiersdorf EUR 387M 165M Dec/2025
Covestro EUR -378M 331M Dec/2025
Demant DKK 427M 690M Dec/2025
Fresenius EUR 361M 17M Dec/2025
Fresenius Medical Care EUR 327M 52.2M Dec/2025
Geberit CHF 103.5M 52.3M Dec/2025
Genmab DKK 31M 370M Dec/2025
Givaudan CHF 479M 113M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
GN Store Nord DKK 344M 271M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Johnson Matthey GBP -18M 93M Dec/2025
Merck EUR 319M 583M Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Philips EUR 395M 211M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
Sika AG CHF 490.2M 63.6M Dec/2025
Smith & Nephew USD 293M 79M Dec/2025
Solvay EUR -95M 129M Dec/2025
UCB EUR 1.08B 608M Dec/2025